The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation
In clinical practice, reducing the burden of persistent atrial fibrillation by pharmacological means is challenging. We explored if blocking the background and the acetylcholine-activated inward rectifier potassium currents (IK1 and IKACh) could be antiarrhythmic in persistent atrial fibrillation. W...
Main Authors: | Catalina Tobón, Laura C. Palacio, Bojjibabu Chidipi, Diana P. Slough, Thanh Tran, Nhi Tran, Michelle Reiser, Yu-Shan Lin, Bengt Herweg, Dany Sayad, Javier Saiz, Sami Noujaim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01392/full |
Similar Items
-
Mimicking Metabolism of a Reversed Chloroquine Antimalarial
by: Kendrick, Kelsie Lynn
Published: (2014) -
Design and Synthesis of Novel Chloroquine-based Antimalarials
by: Murphy, Kevin Vincent
Published: (2015) -
Clinical Pharmacology of the Antimalarial Chloroquine in Children and Their Mothers
by: Gian Maria Pacifici
Published: (2018-06-01) -
Ion currents, action potentials, and noradrenergic responses in rat pulmonary vein and left atrial cardiomyocytes
by: Richard C. Bond, et al.
Published: (2020-05-01) -
In vitro evaluation of marketed antimalarial chloroquine phosphate tablets
by: Amit K. Patel, Bhupendra G. Prajapati, Rubina S. Moria & Chhaganbhai N. Patel
Published: (2005-12-01)